分期血管成形术用于高灌注综合征风险患者的安全性与有效性:单中心回顾性研究
该单中心回顾性研究纳入2010年1月至2018年12月因重度颈动脉狭窄行颈动脉支架置入术的134例患者,对123I-IMP SPECT乙酰唑胺试验显示血流动力学储备严重受损者行分期血管成形术(SAP组),其余行常规颈动脉支架置入术(RS组)。两组均未观察到高灌注综合征;SAP组术后MRI弥散加权成像阳性病灶比例与RS组无统计学显著差异,症状性操作相关并发症亦无统计学显著差异。作者认为对高灌注综合征高风险患者,SAP是预防高灌注综合征的合理治疗策略。
要点
- 对123I-IMP SPECT乙酰唑胺试验显示血流动力学储备严重受损者行分期血管成形术,两组均未发生高灌注综合征。
- 术后MRI弥散加权成像阳性病灶在RS组56例(52.3%)、SAP组16例(64.0%),差异无统计学意义。
- 症状性操作相关并发症RS组5例(4.6%)、SAP组1例(3.8%),差异无统计学意义。
核心结论
- 对高灌注综合征高风险患者,分期血管成形术是预防高灌注综合征的合理治疗策略。
- 与常规颈动脉支架置入术相比,分期血管成形术未增加弥散加权成像阳性病灶或操作相关并发症的发生率。
研究设计与样本
- 单中心回顾性研究,纳入2010年1月至2018年12月因重度颈动脉狭窄行颈动脉支架置入术的134例患者。
- 以123I-IMP SPECT乙酰唑胺试验评估血流动力学储备,严重受损者接受分期血管成形术(SAP组),其余接受常规颈动脉支架置入术(RS组)。
- 26例(19.4%)高灌注综合征风险患者接受分期血管成形术。
关键影像表现/征象
- 两组均未观察到高灌注综合征。
- 术后MRI弥散加权成像阳性病灶在RS组为56例(52.3%),在SAP组为16例(64.0%)。
- 症状性操作相关并发症在RS组为5例(4.6%),在SAP组为1例(3.8%)。
- 上述差异均无统计学意义。
- 出院30天后改良Rankin量表评分下降者4例(3.0%)。
诊断标准与关键数值
- 以123I-IMP SPECT乙酰唑胺试验显示血流动力学储备严重受损作为分期血管成形术的入选条件。
- 术后以MRI弥散加权成像评估新增缺血性病灶,以症状性操作相关并发症评估安全性。
临床应用与阅片要点
- 远端滤器保护与新增弥散加权成像阳性病灶的发生显著相关。
- 作者认为对高灌注综合征高风险患者,分期血管成形术是预防高灌注综合征的合理治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Intracranial hemorrhage following hyperperfusion syndrome (HPS) is a rare but potentially fatal complication after carotid artery stenting (CAS). Staged angioplasty (SAP) is a two-stage form of CAS that can prevent the abrupt increase of cerebral blood flow. In this study, we investigated the safety and efficacy of SAP.
METHODS: One hundred thirty-four patients who underwent CAS for high-grade carotid artery stenosis between January 2010 and December 2018 were enrolled. Patients who showed severe impairment of hemodynamic reserve in 123I-IMP SPECT with acetazolamide received SAP (SAP group), while the others received regular CAS (RS group).
RESULTS: Twenty-six (19.4%) patients at risk for HPS received SAP. HPS was not observed in either group. Diffusion-weighted image (DWI)-positive lesions on postoperative MRI were observed in 56 (52.3%) cases in the RS group and 16 (64.0%) cases in the SAP group. Symptomatic procedure-related complications occurred in 5 (4.6%) cases in the RS group and 1 (3.8%) case in the SAP group. These differences were not statistically significant. Modified Rankin Scale score had declined 30 days after discharge in 4 (3.0%) cases. Distal filter protection was significantly correlated to the occurrence of new DWI-positive lesions.
CONCLUSIONS: For patients at high risk of HPS, SAP was a reasonable treatment strategy to prevent HPS. SAP did not increase the rate of DWI-positive lesions or procedure-related complications compared with regular CAS.
引用
- Murai S, Sugiu K, Hishikawa T, et al. Safety and efficacy of staged angioplasty for patients at risk of hyperperfusion syndrome: a single-center retrospective study. Neuroradiology. 2020. PMID: 31915841. doi:10.1007/s00234-019-02343-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。